Santana, M.R.d.; Argolo, D.S.; Lima, I.S.; Santos, C.C.d.; Victor, M.M.; Ramos, G.d.S.; Nascimento, R.P.d.; Ulrich, H.; Costa, S.L.
Naringenin Exhibits Antiglioma Activity Related to Aryl Hydrocarbon Receptor Activity and IL-6, CCL2, and TNF-α Expression. Brain Sci. 2025, 15, 325.
https://doi.org/10.3390/brainsci15030325
AMA Style
Santana MRd, Argolo DS, Lima IS, Santos CCd, Victor MM, Ramos GdS, Nascimento RPd, Ulrich H, Costa SL.
Naringenin Exhibits Antiglioma Activity Related to Aryl Hydrocarbon Receptor Activity and IL-6, CCL2, and TNF-α Expression. Brain Sciences. 2025; 15(3):325.
https://doi.org/10.3390/brainsci15030325
Chicago/Turabian Style
Santana, Monique Reis de, Deivison Silva Argolo, Irlã Santos Lima, Cleonice Creusa dos Santos, MaurÃcio Moraes Victor, Gabriel dos Santos Ramos, Ravena Pereira do Nascimento, Henning Ulrich, and Silvia Lima Costa.
2025. "Naringenin Exhibits Antiglioma Activity Related to Aryl Hydrocarbon Receptor Activity and IL-6, CCL2, and TNF-α Expression" Brain Sciences 15, no. 3: 325.
https://doi.org/10.3390/brainsci15030325
APA Style
Santana, M. R. d., Argolo, D. S., Lima, I. S., Santos, C. C. d., Victor, M. M., Ramos, G. d. S., Nascimento, R. P. d., Ulrich, H., & Costa, S. L.
(2025). Naringenin Exhibits Antiglioma Activity Related to Aryl Hydrocarbon Receptor Activity and IL-6, CCL2, and TNF-α Expression. Brain Sciences, 15(3), 325.
https://doi.org/10.3390/brainsci15030325
